Skip to main content
. 2013 Sep;5(5):423–437. doi: 10.1177/1941738113481179

Table 4.

Treatment options for tinea gladiatorum14,41,42,53,81

Indication Medication Dosing Regimen Comments
Tinea capitis: Diffuse/inflammatory tinea corporis treatment
 Adult Terbinafine 250 mg, PO, daily for 2-4 wk Potential rare hepatotoxicity, anemia, neutropenia, thrombocytopenia, agranulocytosis. LFT elevations in approximately 3%-4% treated. Possible gastrointestinal upset. Obtain baseline CBC and LFT and repeat every 4-6 wk during treatment.
Itraconazole 200 mg, PO, daily for 2-6 wk Potential rare hepatotoxicity. LFT elevations in approximately 2%-4% treated. Possible gastrointestinal upset. Obtain baseline LFT and repeat every 4-6 wk during treatment.
Ketoconazole 200 mg, PO, daily for 2-4 wk Potential severe hepatotoxicity/hepatic failure (1:10,000 treated), hemolytic anemia, neutropenia. Possible gastrointestinal upset. Avoid alcohol because of liver effects and disulfiram-type effect. Obtain baseline CBC and LFT and repeat every month during treatment.
 Children Griseofulvin (micronized) 20 mg/kg, PO, daily for 8 wk For child >30 kg. Rare hepatotoxicity and photosensitivity. Possible leukopenia and granulocytopenia. Possible gastrointestinal upset. Obtain CBC and LFT at 6 wk of treatment.
Terbinafine Weight, 10-20 kg: 62.5 mg, PO, daily for 2-4 wk For child >2 years old. Potential rare hepatotoxicity, anemia, neutropenia, thrombocytopenia, agranulocytosis. LFT elevations in approximately 3%-4% treated. Possible gastrointestinal upset. Obtain baseline CBC and LFT and repeat every 4-6 wk during treatment.
Weight, 20-40 kg: 125 mg, PO, daily for 2-4 wk
Weight >40 kg: same as adult dosing
Tinea corporis: Limited area treatment
Clotrimazole cream Applied to lesion and surrounding area twice daily
Miconazole cream Applied to lesion and surrounding area twice daily
Terbinafine cream Applied to lesion and surrounding area twice daily
Butenafine cream Applied to lesion and surrounding area once daily
Prophylaxis
 Adult Fluconazole 100 mg, PO, 1x/wk Rare severe hepatotoxicity/hepatic failure, leukopenia, thrombocytopenia, agranulocytosis. Possible gastrointestinal upset. Avoid alcohol because of liver effects and disulfiram-type effect. Obtain baseline CBC and LFT and repeat every 4-6 wk during treatment.

CBC, complete blood count; LFT, liver function test; PO, orally.